Last CNY8.09 CNY
Change Today -0.01 / -0.12%
Volume 3.2M
As of 2:00 AM 12/25/14 All times are local (Market data is delayed by at least 15 minutes).

shandong xinhua pharm co-a (000756) Snapshot

Open
CNY8.10
Previous Close
CNY8.10
Day High
CNY8.15
Day Low
CNY8.02
52 Week High
10/16/14 - CNY10.33
52 Week Low
01/13/14 - CNY4.61
Market Cap
2.9B
Average Volume 10 Days
5.8M
EPS TTM
CNY0.16
Shares Outstanding
307.3M
EX-Date
07/18/14
P/E TM
52.1x
Dividend
CNY0.02
Dividend Yield
0.25%
Current Stock Chart for SHANDONG XINHUA PHARM CO-A (000756)

Related News

No related news articles were found.

shandong xinhua pharm co-a (000756) Related Businessweek News

No Related Businessweek News Found

shandong xinhua pharm co-a (000756) Details

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, is engaged in the development, manufacture, and sale of bulk pharmaceuticals, preparations, and chemical products. The company operates through Bulk Pharmaceuticals, Preparations, Chemical and other products, and Commerce circulations. It provides antipyretics and analgesics; and drugs for central nervous system, steroids, and cardio cerebrovascular systems, as well as finished dosage forms and pharmaceutical intermediates. The company offers its products in various dosages forms, such as tablets, capsules, injections, and ointments. It also provides contract manufacturing services of APIs and pharmaceutical intermediates, as well as OTC and generic products. In addition, the company is involved in the retail and wholesale of pharmaceutical products, as well as offers building management services. It operates in the People's Republic of China, Europe, the United States, and internationally. The company was founded in 1943 and is based in Zibo City, the People's Republic of China.

Founded in 1943

shandong xinhua pharm co-a (000756) Top Compensated Officers

General Manager, Executive Director and Membe...
Total Annual Compensation: CNY490.0K
Executive Chairman, Member of Nomination Comm...
Total Annual Compensation: CNY510.0K
Chairman of the Supervisory Committee
Total Annual Compensation: CNY358.0K
Employee Supervisor
Total Annual Compensation: CNY100.0K
Independent Supervisor
Total Annual Compensation: CNY30.0K
Compensation as of Fiscal Year 2013.

shandong xinhua pharm co-a (000756) Key Developments

Shandong Xinhua Pharmaceutical Co. Ltd., Special/Extraordinary Shareholders Meeting, Dec 22, 2014

Shandong Xinhua Pharmaceutical Co. Ltd., Special/Extraordinary Shareholders Meeting, Dec 22, 2014., at 14:00 China Standard Time. Location: No. 1 Lutai Ave., Hi-tech District. Agenda: To approve election of non-independent directors; to approve election of non-executive independent directors; and to approve election of supervisors.

Shandong Xinhua Pharmaceutical Co. Ltd. Reports Unaudited Consolidated and Company Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Shandong Xinhua Pharmaceutical Co. Ltd. reported unaudited consolidated and company earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, on consolidated basis, the company reported total operating income of RMB 841,786,000 compared to RMB 764,090,000 a year ago. Operating profit was RMB 13,772,000 compared to operating loss of RMB 6,403,000 a year ago. Profit before taxation was RMB 15,437,000 compared to RMB 37,919,000 a year ago. Net profit attributable to the equity holders of the company was RMB 8,116,000 or RMB 0.02 per basic and diluted share compared RMB 30,245,000 or RMB 0.07 per basic and diluted share a year ago. Return on equity of weighted average was 0.45%. For the quarter, on company basis, the company reported total operating income of RMB 450,533,000 compared to RMB 452,545,000 a year ago. Operating loss was RMB 5,051,000 compared to operating loss of RMB 1,930,000 a year ago. Loss before taxation was RMB 2,394,000 compared to profit before taxation of RMB 43,210,000 a year ago. Loss after taxation was RMB 2,394,000 or RMB 0.01 per basic and diluted share compared to profit after taxation of RMB 37,641,000 or RMB 0.08 per basic and diluted share a year ago. For the nine months, on consolidated basis, the company reported total operating income of RMB 2,578,603,000 compared to RMB 2,381,224,000 a year ago. Operating profit was RMB 37,342,000 compared to operating loss of RMB 19,449,000 a year ago. Profit before taxation was RMB 68,182,000 compared to RMB 47,200,000 a year ago. Net profit attributable to the equity holders of the company was RMB 48,103,000 or RMB 0.11 per basic and diluted share compared to net profit attributable to the equity holders of the company of RMB 35,233,000 or RMB 0.08 per basic and diluted share a year ago. Return on weighted average was 2.70%. Net cash flow from operating activities was RMB 215,779,000 against RMB 176,382,000 a year ago. For the nine months, on company basis, the company reported total operating income of RMB 1,448,367,000 compared to RMB 1,403,743,000 a year ago. Operating profit was RMB 4,604,000 compared to operating loss of RMB 5,194,000 a year ago. Profit before taxation was RMB 38,260,000 compared to RMB 47,209,000 a year ago. Profit after taxation was RMB 32,490,000 or RMB 0.08 per basic and diluted share compared to RMB 39,357,000 or RMB 0.09 per basic and diluted share a year ago.

Shandong Xinhua Pharmaceutical Co. Ltd. to Report Q3, 2014 Results on Oct 28, 2014

Shandong Xinhua Pharmaceutical Co. Ltd. announced that they will report Q3, 2014 results on Oct 28, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000756:CH CNY8.09 CNY -0.01

000756 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hebei Iron & Steel Co Ltd CNY3.69 CNY +0.19
Nanjing Iron & Steel Co Ltd CNY2.61 CNY 0.00
Wuhan Iron & Steel Co Ltd CNY3.52 CNY +0.17
View Industry Companies
 

Industry Analysis

000756

Industry Average

Valuation 000756 Industry Range
Price/Earnings 75.8x
Price/Sales 1.0x
Price/Book -- Not Meaningful
Price/Cash Flow 51.2x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG XINHUA PHARM CO-A, please visit www.xhzy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.